| Year |
Citation |
Score |
| 2019 |
Harquail J, LeBlanc N, Ouellette RJ, Robichaud GA. MiRNAs 484 and 210 Regulate Pax-5 Expression and Function in Breast Cancer Cells. Carcinogenesis. PMID 30605519 DOI: 10.1093/Carcin/Bgy191 |
0.366 |
|
| 2018 |
Leblanc N, Harquail J, Crapoulet N, Ouellette RJ, Robichaud GA. Pax-5 Inhibits Breast Cancer Proliferation Through MiR-215 Up-regulation. Anticancer Research. 38: 5013-5026. PMID 30194145 DOI: 10.21873/Anticanres.12820 |
0.386 |
|
| 2018 |
Harquail J, LeBlanc N, Landry C, Crapoulet N, Robichaud GA. Pax-5 Inhibits NF-κB Activity in Breast Cancer Cells Through IKKε and miRNA-155 Effectors. Journal of Mammary Gland Biology and Neoplasia. PMID 30032344 DOI: 10.1007/S10911-018-9404-4 |
0.434 |
|
| 2017 |
Benzina S, Beauregard AP, Guerrette R, Jean S, Faye MD, Laflamme M, Maïcas E, Crapoulet N, Ouellette RJ, Robichaud GA. Pax-5 is a potent regulator of E-cadherin and breast cancer malignant processes. Oncotarget. PMID 28076843 DOI: 10.18632/Oncotarget.14511 |
0.427 |
|
| 2016 |
Benzina S, Harquail J, Guerrette R, O'Brien P, Jean S, Crapoulet N, Robichaud GA. Breast Cancer Malignant Processes are Regulated by Pax-5 Through the Disruption of FAK Signaling Pathways. Journal of Cancer. 7: 2035-2044. PMID 28070224 DOI: 10.7150/Jca.15200 |
0.419 |
|
| 2015 |
Picot N, Guerrette R, Beauregard AP, Jean S, Michaud P, Harquail J, Benzina S, Robichaud GA. Mammaglobin 1 promotes breast cancer malignancy and confers sensitivity to anticancer drugs. Molecular Carcinogenesis. PMID 26207726 DOI: 10.1002/Mc.22358 |
0.413 |
|
| 2015 |
Beauregard AP, Harquail J, Lassalle-Claux G, Belbraouet M, Jean-Francois J, Touaibia M, Robichaud GA. CAPE Analogs Induce Growth Arrest and Apoptosis in Breast Cancer Cells. Molecules (Basel, Switzerland). 20: 12576-89. PMID 26184141 DOI: 10.3390/Molecules200712576 |
0.378 |
|
| 2015 |
Benzina S, Harquail J, Jean S, Beauregard AP, Colquhoun CD, Carroll M, Bos A, Gray CA, Robichaud GA. Deoxypodophyllotoxin isolated from Juniperus communis induces apoptosis in breast cancer cells. Anti-Cancer Agents in Medicinal Chemistry. 15: 79-88. PMID 24913660 DOI: 10.2174/1871520614666140608150448 |
0.409 |
|
| 2015 |
Harquail JM, Robichaud GA. Abstract P4-07-10: MiRNAs are important regulators of Pax-5 expression and function during breast cancer progression Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-07-10 |
0.342 |
|
| 2015 |
Guerrette R, Picot N, Robichaud G. Abstract P4-05-17: Mammaglobin is a potent regulator of breast cancer processes leading to disease progression Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P4-05-17 |
0.392 |
|
| 2015 |
Benzina S, O'Brien P, Beauregard A, Guérrette R, Jean S, Robichaud G. Abstract P2-07-03: Pax-5 regulates EMT and MET in breast cancer through FAK1 regulation Cancer Research. 75. DOI: 10.1158/1538-7445.Sabcs14-P2-07-03 |
0.365 |
|
| 2014 |
Cormier K, Harquail J, Ouellette RJ, Tessier PA, Guerrette R, Robichaud GA. Intracellular expression of inflammatory proteins S100A8 and S100A9 leads to epithelial-mesenchymal transition and attenuated aggressivity of breast cancer cells Anti-Cancer Agents in Medicinal Chemistry. 14: 35-45. PMID 24041228 DOI: 10.2174/18715206113136660333 |
0.41 |
|
| 2013 |
Harquail JM, Robichaud GA. Abstract 3094: MiRNAs 484 and 210 control Pax-5 expression and function in breast cancer. Cancer Research. 73: 3094-3094. DOI: 10.1158/1538-7445.Am2013-3094 |
0.324 |
|
| 2013 |
Picot N, Beauregard A, Guerette R, Jean S, Robichaud GA. Abstract 298: Breast cancer malignancy and drug sensitivity are regulated by mammaglobin 1. Cancer Research. 73: 298-298. DOI: 10.1158/1538-7445.Am2013-298 |
0.402 |
|
| 2013 |
Benzina S, O'Brien P, Guerrette R, Robichaud G. Abstract 292: Breast cancer malignancy is regulated by PAX5 through the disruption of FAK1 signaling. Cancer Research. 73: 292-292. DOI: 10.1158/1538-7445.Am2013-292 |
0.418 |
|
| 2013 |
Robichaud GA, Picot N, Jean S, Carpenter C, Gray CA. Abstract 2266: The characterization of anti-breast cancer compounds isolated from theJuniperus communis. Cancer Research. 73: 2266-2266. DOI: 10.1158/1538-7445.Am2013-2266 |
0.419 |
|
| 2012 |
Harquail J, Benzina S, Robichaud GA. MicroRNAs and breast cancer malignancy: an overview of miRNA-regulated cancer processes leading to metastasis. Cancer Biomarkers : Section a of Disease Markers. 11: 269-80. PMID 23248185 DOI: 10.3233/Cbm-120291 |
0.37 |
|
| 2012 |
Audet B, Torresilla C, Robichaud GA, Tremblay MJ, Barbeau B. Molecular mechanism leading to preferential replication of HIV-1 in Cd45ro Cd4+ t lymphocytes Tyrosine and Aspartic Acid: Properties, Sources and Health Benefits. 57-77. |
0.52 |
|
| 2011 |
O'Brien P, Morin P, Ouellette RJ, Robichaud GA. The Pax-5 gene: a pluripotent regulator of B-cell differentiation and cancer disease. Cancer Research. 71: 7345-50. PMID 22127921 DOI: 10.1158/0008-5472.Can-11-1874 |
0.412 |
|
| 2011 |
Crapoulet N, O'Brien P, Ouellette RJ, Robichaud GA. Coordinated expression of Pax-5 and FAK1 in metastasis. Anti-Cancer Agents in Medicinal Chemistry. 11: 643-9. PMID 21707507 DOI: 10.2174/187152011796817637 |
0.423 |
|
| 2011 |
Doiron J, Soultan AH, Richard R, Touré MM, Picot N, Richard R, Cuperlovi?-Culf M, Robichaud GA, Touaibia M. Synthesis and structure-activity relationship of 1- and 2-substituted-1,2,3-triazole letrozole-based analogues as aromatase inhibitors. European Journal of Medicinal Chemistry. 46: 4010-24. PMID 21703734 DOI: 10.1016/J.Ejmech.2011.05.074 |
0.304 |
|
| 2009 |
Boudreau LH, Picot N, Doiron J, Villebonnet B, Surette ME, Robichaud GA, Touaibia M. Caffeoyl and cinnamoyl clusters with anti-inflammatory and anti-cancer effects. Synthesis and structure-activity relationship New Journal of Chemistry. 33: 1932-1940. DOI: 10.1039/B907878A |
0.375 |
|
| 2008 |
Robichaud GA, Perreault JP, Ouellette RJ. Development of an isoform-specific gene suppression system: the study of the human Pax-5B transcriptional element. Nucleic Acids Research. 36: 4609-20. PMID 18617575 DOI: 10.1093/Nar/Gkn432 |
0.38 |
|
| 2008 |
Bujold‐Michaud G, Laflamme M, Ouellette R, Robichaud G. Implication of mammaglobin 1 and lipophilin B in breast cancer The Faseb Journal. 22: 287-287. DOI: 10.1096/Fasebj.22.2_Supplement.287 |
0.342 |
|
| 2004 |
Robichaud GA, Nardini M, Laflamme M, Cuperlovic-Culf M, Ouellette RJ. Human Pax-5 C-terminal isoforms possess distinct transactivation properties and are differentially modulated in normal and malignant B cells. The Journal of Biological Chemistry. 279: 49956-63. PMID 15385562 DOI: 10.1074/Jbc.M407171200 |
0.373 |
|
| 2002 |
Ryckman C, Robichaud GA, Roy J, Cantin R, Tremblay MJ, Tessier PA. HIV-1 transcription and virus production are both accentuated by the proinflammatory myeloid-related proteins in human CD4+ T lymphocytes. Journal of Immunology (Baltimore, Md. : 1950). 169: 3307-13. PMID 12218151 DOI: 10.4049/Jimmunol.169.6.3307 |
0.6 |
|
| 2002 |
Robichaud GA, Barbeau B, Fortin JF, Rothstein DM, Tremblay MJ. Nuclear factor of activated T cells is a driving force for preferential productive HIV-1 infection of CD45RO-expressing CD4+ T cells. The Journal of Biological Chemistry. 277: 23733-41. PMID 11956207 DOI: 10.1074/Jbc.M201563200 |
0.645 |
|
| 2001 |
Barbeau B, Robichaud GA, Fortin JF, Tremblay MJ. Negative regulation of the NFAT1 factor by CD45: implication in HIV-1 long terminal repeat activation. Journal of Immunology (Baltimore, Md. : 1950). 167: 2700-13. PMID 11509614 DOI: 10.4049/Jimmunol.167.5.2700 |
0.66 |
|
| 2001 |
Fortin JF, Barbeau B, Robichaud GA, Paré ME, Lemieux AM, Tremblay MJ. Regulation of nuclear factor of activated T cells by phosphotyrosyl-specific phosphatase activity: a positive effect on HIV-1 long terminal repeat-driven transcription and a possible implication of SHP-1. Blood. 97: 2390-400. PMID 11290602 DOI: 10.1182/Blood.V97.8.2390 |
0.654 |
|
| 2000 |
Genois N, Robichaud GA, Tremblay MJ. Mono Mac 1: a new in vitro model system to study HIV-1 infection in human cells of the mononuclear phagocyte series. Journal of Leukocyte Biology. 68: 854-64. PMID 11129653 DOI: 10.1189/Jlb.68.6.854 |
0.578 |
|
| Show low-probability matches. |